- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Catumaxomab is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- L01FX03 Catumaxomab · Cancer medicines (antineoplastics), subgroup L01F, subgroup L01FX
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Identifiers
- UNII M2HPV837HOCAS 509077-98-9DrugBank DB06607Q408155
All presentations
No presentations of Catumaxomab are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Catumaxomab available for export from India?
No presentation of Catumaxomab is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Catumaxomab authorised in the European Union?
Yes. Catumaxomab has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Catumaxomab need cold chain shipping?
No listed presentation of Catumaxomab is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Catumaxomab in?
Catumaxomab is classified under ATC code L01FX03 (Catumaxomab).
References
- Korjuny: European public assessment report (EPAR). European Medicines Agency. Retrieved 6 May 2026
Request Catumaxomab for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.